-
Mashup Score: 8ARROW study: pralsetinib in RET fusion+ tumors - 4 year(s) ago
Vivek Subbiah, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ARROW study (NCT03037385), which…
Source: VJOncologyCategories: Hem/Oncs, Latest HeadlinesTweet
RT @VJOncology: VIDEO: ARROW study: pralsetinib in RET fusion+ tumors w/ @VivekSubbiah of @MDAndersonNews: https://t.co/R6D69lLHoj @VJOnco…